Interest in the use of psychedelic substances for the treatment of mental disorders is increasing. Processes that may affect therapeutic change are not yet fully understood. 

We are working jointly with our partners and collaborators on psychedelic treatments for mental health disorders.

Imperial College London

We are currently focussed on:

The use of psychedelics in mental health care.

Working with Imperial Technology Transfer agent to bring products to market.

On providing hospital grade psilocybin to Imperial and physicians worldwide to research and develop medicines.

Manufacturing micro-dosing capsules for ongoing chronic health issues which psilocybin has proven beneficial.